Ulrich Laufs

2019 ESC/EAS Guidelines for the management of dyslipidaemias: <i>lipid modification to reduce cardiovascular risk</i>

François Mach, Colin Baigent, Alberico L. Catapano et al. · European Heart Journal · 2019 · 8.9K citations · Full text

Medicine, Cardiology, Internal Medicine +17

Upregulation of Endothelial Nitric Oxide Synthase by HMG CoA Reductase Inhibitors

Ulrich Laufs, Vito La Fata, Jorge Plutzky et al. · Circulation · 1998 · 1.8K citations · Full text

Life Sciences, Biochemistry, Pharmacology +16

Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

Jan Borén, M. John Chapman, Ronald M. Krauss et al. · European Heart Journal · 2020 · 1.5K citations

Medicine, Cardiology, Cardiovascular Genetics +10

Post-transcriptional Regulation of Endothelial Nitric Oxide Synthase mRNA Stability by Rho GTPase

Ulrich Laufs, James K. Liao · Journal of Biological Chemistry · 1998 · 1K citations · Full text

Life Sciences, Molecular Biology, Pharmacology +13

Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase

Matthias Endres, Ulrich Laufs, Zhihong Huang et al. · Proceedings of the National Academy of Sciences · 1998 · 970 citations

Medicine, Pharmacology, Pharmacotherapy +17